drugset / Trial / NCT00330473

A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes

NCT00330473

Phase 3 Completed 1019 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

A study to compare insulin use and its effect on glucose control and other outcomes in patients with Type 2 diabetes who together with their healthcare provider manage their disease by discussing and agreeing on the diabetes treatment chosen from a selection of available treatment options.

Timeline

Start
2006-06
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Inhaled
Comparator Insulin Protein / enzyme biologic Oral